Transvenous shock-only implantable cardioverter defibrillator after an atrio-pulmonary Fontan surgery.
Keiko ToyoharaDaigo YagishitaYoshimichi KudoTomomi NishimuraDaiji TakeuchiYasuko TomizawaShohei KataokaPublished in: Pacing and clinical electrophysiology : PACE (2020)
A 42-year-old woman with tricuspid atresia who underwent a Fontan surgery (atrio-pulmonary connection) was admitted to our hospital due to symptomatic ventricular tachycardia (VT). A defibrillation lead was implanted in a distal site of a coronary vein since there was no usual entry to the ventricle. Ventricular pacing was impossible due to the high threshold, however, good sensing was obtained. Three years later, she felt palpitations and a subsequent shock therapy while climbing stairs. The cardioverter data showed that an appropriate cardioversion therapy successfully converted VT to normal rhythm.
Keyphrases
- minimally invasive
- pulmonary hypertension
- coronary artery bypass
- atrial fibrillation
- mitral valve
- coronary artery disease
- coronary artery
- heart failure
- aortic stenosis
- cardiac arrest
- pulmonary artery
- healthcare
- left ventricular
- surgical site infection
- transcatheter aortic valve replacement
- aortic valve
- electronic health record
- machine learning
- emergency department
- stem cells
- big data
- pulmonary arterial hypertension
- mesenchymal stem cells
- cell therapy
- ejection fraction
- bone marrow